<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE342nnn/GSE342431/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE342431</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Transcriptomic effects of combined AZD4573 and SMAP-2 treatment in resting and anti-CD3/CD28-activated primary human CD4+ T cells</name><description>This study characterized the effects of combined CDK9 inhibition and PP2A activation on host gene expression in primary human CD4+ T cells. In the broader study, the CDK9 inhibitor AZD4573 and the PP2A activator SMAP-2 cooperatively suppressed HIV transcription and promoted durable transcriptional silencing. The RNA-seq experiment was performed to determine whether this drug combination caused broad or selective host-transcriptome changes in uninfected primary CD4+ T cells under resting and T-cell receptor-activated conditions. Primary CD4+ T cells from three independent HIV-negative donors were either maintained without stimulation or activated for 48 h with plate-bound anti-CD3 and anti-CD28 antibodies. Resting and activated cells were subsequently treated for 24 h with either 0.1% DMSO or a combination of 5 nM AZD4573 and 5 μM SMAP-2. Within each activation state, drug-treated samples were compared with donor-matched DMSO controls. The transcriptional response to AZD4573 plus SMAP-2 was dependent on T-cell activation state. Resting CD4+ T cells exhibited a larger number of differentially expressed transcripts, many corresponding to unannotated protein-coding loci or long non-coding RNAs, with the P-TEFb-responsive gene MYC among the annotated downregulated genes. Activated CD4+ T cells exhibited fewer transcriptional changes; among these, HEXIM1 was downregulated and the transcriptional corepressor SLFN5 was upregulated. These data define the host-transcriptome effects of combined AZD4573 and SMAP-2 treatment in resting and activated primary human CD4+ T cells.</description><dates><publication>2026/08/05</publication></dates><accession>GSE342431</accession><cross_references><GSM>GSM9930511</GSM><GSM>GSM9930510</GSM><GSM>GSM9930509</GSM><GSM>GSM9930506</GSM><GSM>GSM9930516</GSM><GSM>GSM9930505</GSM><GSM>GSM9930508</GSM><GSM>GSM9930507</GSM><GSM>GSM9930513</GSM><GSM>GSM9930512</GSM><GSM>GSM9930515</GSM><GSM>GSM9930514</GSM><GPL>34284</GPL><GSE>342431</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>